We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Long-term efficacy data on two multiple sclerosis drugs — Novartis’ Gilenya and Sanofi’s Lemtrada — back their ability to keep relapsing MS at bay, while Roche’s investigational ocrelizumab performed well in both relapsing and primary progressive forms of the disease. Read More
Delegates from more than 20 countries in Latin America and the Caribbean are calling for comprehensive health and medicines policies and strategies that provide long-term, sustainable and effective solutions for ensuring access to life-saving drugs. Read More
The U.S. Food and Drug Administration has banned imports of drugs made at Mumbai, India-based Polydrug Laboratories, marking the latest development in ongoing issues involving Indian manufacturers. Read More